Yaşlı Hastalarda Meme Kanseri Yönetimi: Geriatrik Değerlendirme ve Cerrahi Kararlar

Fusco D, Allocca E, Villani ER, Franza L, Laudisio A, Colloca G. An update in breast cancer management for elderly patients. Transl Cancer Res. 2018;7(Suppl 3):S319–S328. doi:10.21037/tcr.2018.03.21

Morgan JL, Richards P, Zaman O, et al. The decision-making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK. Cancer Biol Med. 2015;12(4):308–315. doi:10.7497/j.issn.2095-3941.2015.0080

Angarita FA, Hoppe EJ, Ko G, et al. Why Do Older Women Avoid Breast Cancer Surgery? A Qualitative Analysis of Decision-Making Factors. J Surg Res. 2021;268:623–633. doi:10.1016/j.jss.2021.06.088

Webster S, Lawn S, Chan R, Koczwara B. The role of comorbidity assessment in guiding treatment decision-making for women with early breast cancer: a systematic literature review. Support Care Cancer. 2020;28:1041–1050. doi:10.1007/s00520-019-05218-w

Festen S, Kok M, Hopstaken JS, et al. How to incorporate geriatric assessment in clinical decision-making for older patients with cancer. An implementation study. J Geriatr Oncol. 2019;10(6):951–959. doi:10.1016/j.jgo.2019.04.006

Taira N, Sawaki M, Takahashi M, Shimozuma K, Ohashi Y. Comprehensive geriatric assessment in elderly breast cancer patients. Breast Cancer. 2010;17:183–189. doi:10.1007/s12282-009-0167-z

Munir A, Huws A, Khan S, et al. Geriatric assessment tool application in treatment recommendations for older women with breast cancer. The Breast. 2022;63:101–107. https://doi.org/10.1016/j.breast.2022.03.012

Abdel-Razeq H, Abu Rous F, Abuhijla F, Abdel-Razeq N, Edaily S. Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects. Clin Interv Aging. 2022;17:1445–1460. https://doi.org/10.2147/CIA.S365497

Sawaki M, Shimomura A, Shien T, Iwata H. Management of breast cancer in older patients. Jpn J Clin Oncol. 2022;52(7):682–689. https://doi.org/10.1093/jjco/hyac054

Allen T, James M, Frampton C, Robinson B, Withers N. Care of seniors with breast cancer – treatment received and refining decision making. Clin Oncol. 2022;34:472–479. doi:10.1016/j.clon.2022.01.006

Ramana PD, Jabi G. Utility of geriatric assessment tools in the management of breast cancers. J Radiat Cancer Res. 2025;16(2):51–54. doi:10.4103/jrcr.jrcr_38_24

Ji J, Sun CL, Cohen HJ, Muss HB, Bae M, Sedrak MS. Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors. J Natl Cancer Inst. 2023;115:578-585.

Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ⩾65 years. Br J Cancer. 2007;96(8):1197-203. doi:10.1038/sj.bjc.6603709

Fu MR, Xu B, Liu Y, Axelrod D. Comorbidities and quality of life among breast cancer survivors: a prospective study. J Pers Med. 2015;5(3):229-42. doi:10.3390/jpm5030229

Soubeyran P, Bellera C, Goyard J, Heitz D, Curé H, Rousselot H, et al. Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study. PLoS One. 2014;9(12):e115060. doi:10.1371/journal.pone.0115060

Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. Predicting chemotherapy toxicity in older adults with cancer: the Cancer and Aging Research Group (CARG) score. J Clin Oncol. 2011;29(25):3457-65. doi:10.1200/JCO.2011.34.7625

Bellera CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, et al. Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012;23(8):2166-72. doi:10.1093/annonc/mdr582

Mohile SG, Epstein RM, Hurria A, Heckler C, Canin B, Culakova E, et al. Communication with older patients with cancer using geriatric assessment: a cluster-randomized clinical trial from the National Cancer Institute Community Oncology Research Program. JAMA Oncol. 2015;1(7):897-905. doi:10.1001/jamaoncol.2015.296

Monib S, Elkorety M, Habashy H. Adequate Assessment Can Affect the Management of Breast Cancer in Geriatric Population. Indian J Surg Oncol. 2021;12(4):785–791.

Natale M, Di Leone A, Fusco D, et al. Advancing Breast Cancer Care in Patients Aged 80 and Above: A Personalized and Multidisciplinary Management to Better Outcomes. J Pers Med. 2025;15:90.

Machado e Costa P, Debiasi M, Reus BdS, et al. Surgical choices and complications in elderly women: a single center retrospective analysis in frail vs. non-frail breast cancer patients. Eur J Plast Surg. 2023;46:1069–1080.

Cornell LF, Fentiman IS, Mangoni AA, Wildiers H. Special considerations of breast cancer management in elderly patients. Breast Cancer Manage. 2020;9(2):BMT-2020-0023. doi:10.2217/bmt-2020-0023

Albrand G, Terret C. Early breast cancer in the elderly: assessment and management considerations. Drugs Aging. 2008;25(1):35–45. doi:10.2165/00002512-200825010-00004

Syed BM, Al-Khyatt W, Johnston SJ, Wong DW, Winterbottom L, Kennedy H, et al. Long-term clinical outcome of older women with early operable primary breast cancer managed non-operatively with tamoxifen. Breast. 2011;20(6):575–580. doi:10.1016/j.breast.2011.07.010

Scheepers ERM, van der Molen LF, van den Bos F, Burgmans JP, van Huis-Tanja LH, Hamaker ME. The G8 frailty screening tool and the decision-making process in older breast cancer patients. Eur J Cancer Care. 2021;30:e13357.

Lifford KJ, Witt J, Burton M, Caldon L, Wyld L, et al. Understanding older women’s decision making and coping in the context of breast cancer treatment. BMC Med Inform Decis Mak. 2015;15:45. doi:10.1186/s12911-015-0167-1

Samain E, Marty J. Anesthesia for breast cancer surgery in the elderly. Drugs Aging. 2002;19(12):841-851. doi:10.2165/00002512-200219120-00003

Extermann M, Brain E, Canin B, et al. Priorities for the global advancement of care for older adults with cancer: an International Society of Geriatric Oncology consensus. Lancet Oncol. 2021;22(12):e536–e545. doi:10.1016/S1470-2045(21)00463-7

Bertozzi S, Londero AP, Diaz-Nañez JA, et al. Breast cancer care for the aging population: a focus on age-related disparities in breast cancer treatment. BMC Cancer. 2025;25:492. doi:10.1186/s12885-025-13594-2

Burton M, Collins KA, Lifford KJ, Brain K, Wyld L. The information needs and decision-making preferences of older women offered a choice between surgery and primary endocrine therapy for early breast cancer. Psychooncology. 2011;20(12):1346–1353. doi:10.1002/pon.1849

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687–1717.

Burstein HJ, Temin S, Anderson H, et al. Adjuvant endocrine therapy for women with hormone receptor–positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2014;32:2255–2269.

Sedjo RL, Devine S. Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer. Breast Cancer Res Treat. 2011;125:191–200.

Bui QT, Mortimer JE, Pal SK. Endocrine therapy for breast cancer in the elderly: making the right choices. Cancer Treat Rev. 2015;41:380–388.

Muss HB, Berry DA, Cirrincione C, et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009;360:2055–2065.

Magnuson A, Allore H, Cohen HJ, et al. Geriatric assessment with management in cancer care: current evidence and potential mechanisms for future research. J Geriatr Oncol. 2016;7(4):242–248. doi:10.1016/j.jgo.2016.02.007

Lichtman SM, Wildiers H, Launay-Vacher V, et al. International Society of Geriatric Oncology (SIOG) recommendations for the assessment of geriatric patients with cancer undergoing chemotherapy. Lancet Oncol. 2007;8:1149–1159.

Wildiers H, Brain E, Cardoso F, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2012;13:e148–e160.

Biganzoli L, Wildiers H, Oakman C, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol. 2012;13(4):e148-e160. doi:10.1016/S1470-2045(11)70383-7

Kenis C, Decoster L, Van Puyvelde K, et al. Geriatric screening tools are useful to predict survival in older patients with cancer. J Clin Oncol. 2014;32:19–26.

Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397:1750–1769.

Eiermann W, Paepke S, Appfelstaedt J, et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study. Ann Oncol. 2001;12:1527–1532.

Jones SE, Savin MA, Holmes FA, et al. Phase III trial comparing doxorubicin and cyclophosphamide with docetaxel in the adjuvant treatment of operable breast cancer. J Clin Oncol. 2006;24:5381–5387.

Hipólito-Reis H, Santos J, Almeida P, et al. Implementation of an Oncogeriatric Unit for Frail Older Patients with Breast Cancer: Preliminary Results. Curr Oncol. 2024;31:7809–7819. https://doi.org/10.3390/curroncol31120575

Neal D, Morgan JL, Kenny R, Ormerod T, Reed MWR. Is there evidence of age bias in breast cancer health care professionals’ treatment of older patients? Eur J Surg Oncol. 2022;48:2401–2407. https://doi.org/10.1016/j.ejso.2022.07.003

Morgan JL, Reed MW, Wyld L. Primary endocrine therapy as a treatment for older women with operable breast cancer – a comparison of randomised controlled trial and cohort study findings. Eur J Surg Oncol. 2014;40(6):676–684. doi:10.1016/j.ejso.2014.02.227

Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results. Lancet Oncol. 2013;14:1086–1094.

Brunt AM, Haviland JS, Wheatley DA, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised trial. Lancet. 2020;395:1613–1626.

Biganzoli L, Battisti NML, Wildiers H, et al. Updated recommendations regarding the management of older patients with breast cancer: a joint paper from SIOG and EUSOMA. Lancet Oncol. 2021;22:e327–e340.

Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol. 2015;26(2):288–300. doi:10.1093/annonc/mdu210

Caldon LJM, Walters SJ, Reed MWR. Changing trends in the decision-making preferences of women with early breast cancer. BMJ Open. 2011;1:e000091. doi:10.1136/bmjopen-2011-000091

Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27:1361–1367.

Wang T, Baskin A, Dossett LA. Patient Perspectives on Treatment Options for Older Women With Early-Stage Breast Cancer: A Qualitative Study. JAMA Netw Open. 2020;3(4):e2030751. doi:10.1001/jamanetworkopen.2020.30751

Rodin D, Mohile S, Mohile NA. Patient and family engagement in cancer care: lessons for geriatric oncology. J Geriatr Oncol. 2019;10:653–659.

McCarthy EP, Phillips RS, Zhong Z, Drews RE, Lynn J. Dying with cancer: patients’ function, symptoms, and care preferences as death approaches. J Am Geriatr Soc. 2000;48:S110–S121.

Mohile SG, Dale W, Somerfield MR, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol. 2018;36(22):2326–2347. doi:10.1200/JCO.2018.78.8687

Diouf M, Filleron T, Bouchardy C, et al. Quality of life in older patients with cancer: a prospective European survey. Ann Oncol. 2016;27:1983–1990.

Mohile SG, Dale W, Somerfield MR, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol. 2018;36:2326–2347.

Fessele KL, Hayat MJ, Mayer DK, et al. Palliative surgery for advanced breast cancer: outcomes and quality of life considerations. J Palliat Med. 2014;17:47–53.

Badwe RA, Parmar V, Hawaldar R, et al. Surgical palliation for advanced breast cancer: a randomized controlled trial. Breast. 2013;22:308–314.

Kissane DW, Grabsch B, Clarke DM, et al. Supportive-expressive group therapy: the transformation of existential ambivalence into creative living while enhancing adherence to anti-cancer therapies. Psychooncology. 2004;13:755–768.

Hamaker ME, O’Donnell S, van Leeuwen B, et al. Personalized care for older adults with cancer: the role of artificial intelligence and decision support systems. J Geriatr Oncol. 2023;14:101482.

Kadambi S, Soto-Perez-de-Celis E, Garg T, et al. Social support for older adults with cancer. J Geriatr Oncol. 2019.

Ma X, Zhang Y, Li J, et al. Adjuvant chemotherapy and survival outcomes in older women with hormone receptor-positive and HER2-negative breast cancer: a retrospective cohort study. BMJ Open. 2024;14(3):e078782. doi:10.1136/bmjopen-2023-078782

Ratosa I, Montero A, Ciervide R, Alvarez B, García-Aranda M, Valero J, et al. Ultra-hypofractionated one-week locoregional radiotherapy for patients with early breast cancer: acute toxicity results. Clin Transl Radiat Oncol. 2024;100764. doi:10.1016/j.ctro.2024.100764